Brief: Arocell Says FDA Informs That Review Of Arocells 510(k) Submission To Resume At Latest April 15
Feb 20 (Reuters) - AroCell AB (publ) AROC.ST :
* AROCELL - FDA INFORMS THAT REVIEW OF AROCELLS
510(K)SUBMISSION
WILL RESUME AT LATEST APRIL 15TH 2021
Source text for Eikon: ID:nNDL7fG4Vx
Further company coverage: AROC.ST
((Reuters.Briefs@thomsonreuters.com;))